The emerging multiorgan oncogenic role of SRC-1 is still being studied, especially its roles in promoting breast cancer, prostate cancer, gastrointestinal cancer, neurological cancer, and genital system cancer. This evidence concerns the gene NCOA1 and prostate carcinoma.